In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-11-13
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$2.00+7,0003,229,9130%+$13,994
M
2018-11-12
VIVOMeridian Bioscience IncBaldini LawrenceEVP, Global OperationsS - Sale$19.41-35,10166,253-35%-$681,229
2018-11-09
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$2.09+13,0003,222,9130%+$27,225
2018-11-07
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$2.04+3633,209,9130%+$740
2018-11-06
IDXXIdexx Laboratories Inc /deStuder JacquelineCVP, Gen. Counsel, SecretaryS - Sale$201.28-3,3134,951-40%-$666,823
2018-10-26
NYMXNymox Pharmaceutical CorpAverback PaulCEO, 10%S - Sale$1.75-100,00023,331,4480%-$175,000
2018-10-29
NYMXNymox Pharmaceutical CorpAverback PaulCEO, 10%S - Sale$2.50-1,687,60021,643,948-7%-$4,219,000
2018-10-28
NYMXNymox Pharmaceutical CorpLanham Randall JGCP - Purchase$1.72+2,900152,900+2%+$4,988
2018-11-02
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.98+7,0003,209,5500%+$13,842
D
2018-10-31
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$65.10-7,217294,313-2%-$469,827
2018-11-01
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.90+6,0003,202,5500%+$11,400
2018-11-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$15.50-3,0009,000-25%-$46,500
2018-10-31
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.79+12,0003,196,5500%+$21,499
2018-10-30
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.78+6,0003,184,5500%+$10,665
2018-10-25
NYMOXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.62+10,0003,178,5500%+$16,225
2018-10-22
NYMOXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.67+8,0003,168,5500%+$13,340
2018-10-22
NYMOXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.67+8,00013,340+150%+$13,340
M
2018-10-01
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale$16.71-20,000433,469-4%-$334,260
D
2018-09-28
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$65.19-25,250294,313-8%-$1,646,048
2018-09-26
NEOGNeogen CorpAdent John EdwardPres, CEOP - Purchase$73.58+4,3004,300New+$316,394
2018-09-26
NEOGNeogen CorpTobin James PDirP - Purchase$73.37+5004,766+12%+$36,685
D
2018-09-25
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$18.42-86,100453,469-16%-$1,585,768
D
2018-09-11
QDELQuidel Corp /de/Russell Edward KeithS.VP, N.A. Commercial OpsS - Sale+OE$72.29-13,0008,887-59%-$939,732
D
2018-09-07
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$14.95-40,000485,296-8%-$598,000
D
2018-08-30
QDELQuidel Corp /de/Buechler Kenneth FDirS - Sale+OE$75.01-5,00048,269-9%-$375,039
D
2018-08-30
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$89.37-24,000736,226-3%-$2,144,849
D
2018-08-30
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$89.08-3,60013,470-21%-$320,678
D
2018-08-30
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$89.05-7,20037,575-16%-$641,191
2018-08-28
QDELQuidel Corp /de/Polan Mary Lake Ph DDirS - Sale$70.80-2,35815,179-13%-$166,938
2018-08-24
VIVOMeridian Bioscience IncMcIlwraith JohnDirP - Purchase$15.62+2,0006,000+50%+$31,250
2018-08-24
CLDXCelldex Therapeutics, Inc.Marino James JDirP - Purchase$0.48+40,00065,997+154%+$19,200
M
2018-08-23
QDELQuidel Corp /de/Polan Mary Lake Ph DDirS - Sale$70.03-16,00217,537-48%-$1,120,557
D
2018-08-21
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale+OE$242.71-11,37218,640-38%-$2,760,072
D
2018-08-21
IDXXIdexx Laboratories Inc /deStuder JacquelineCVP, Gen. Counsel, SecretaryS - Sale+OE$244.03-11,6197,634-60%-$2,835,375
D
2018-08-21
IDXXIdexx Laboratories Inc /deLane MichaelCorporate VPS - Sale+OE$243.78-5,9123,925-60%-$1,441,211
DM
2018-08-21
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$245.50-30,0001,171,469-2%-$7,365,145
2018-08-23
VRMLVermillion, Inc.Beechey Robert HarryCFOP - Purchase$0.61+75,000175,000+75%+$45,750
M
2018-08-14
VRMLVermillion, Inc.Lafrance James TDirS - Sale$0.50-23,400298,018-7%-$11,812
D
2018-08-17
QDELQuidel Corp /de/Steward Randall JCFOS - Sale+OE$70.15-38,16231,790-55%-$2,677,072
D
2018-08-17
QDELQuidel Corp /de/Bujarski Robert JosephSVP, Bus Dev, GCS - Sale+OE$70.15-38,55041,381-48%-$2,704,248
D
2018-08-17
QDELQuidel Corp /de/Abney Michael Donald Jr.SVP - DistributionS - Sale+OE$70.40-17,5968,721-67%-$1,238,806
2018-08-17
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$0.52+97,000178,063+120%+$50,440
2018-08-16
ICCCImmucell Corp /de/Tomsche David ScottDirP - Purchase$6.67+3,00075,789+4%+$20,010
D
2018-08-15
QDELQuidel Corp /de/Brown Thomas DDirS - Sale+OE$70.12-15,60053,958-22%-$1,093,872
2018-08-15
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$0.51+19,10081,063+31%+$9,741
2018-08-16
VNRXVolitionrx LtdRootsaert Rodney GerardSecretaryP - Purchase$1.91+5,0001,017,5460%+$9,550
2018-08-16
VNRXVolitionrx LtdReynolds Cameron JohnPres, CEOP - Purchase$1.91+6,5002,162,9670%+$12,415
2018-08-14
VRMLVermillion, Inc.Beechey Robert HarryCFOP - Purchase$0.52+100,000100,000New+$52,000
2018-08-10
QDELQuidel Corp /de/Slacik Charles PDirS - Sale$68.28-1,0007,820-11%-$68,284
2018-08-14
NEOGNeogen CorpHerbert James LExec COBS - Sale$83.62-13,000413,035-3%-$1,087,037
D
2018-08-10
NEOGNeogen CorpParnell Jack CDirS - Sale+OE$83.97-2,41817,655-12%-$203,039
2018-08-08
NEOGNeogen CorpHerbert James LExec COBS - Sale$83.28-13,000426,035-3%-$1,082,688
D
2018-08-06
IDXXIdexx Laboratories Inc /deStuder JacquelineCVP, Gen. Counsel, SecretaryS - Sale+OE$242.37-8,5985,849-60%-$2,083,871
D
2018-08-03
IDXXIdexx Laboratories Inc /deVandebroek Sophie V.DirS - Sale+OE$240.64-3,2658,848-27%-$785,695
2018-08-03
IDXXIdexx Laboratories Inc /deClaflin Bruce L.DirP - Purchase$242.12+4151,415+42%+$100,480
M
2018-08-06
NEOGNeogen CorpHerbert James LExec COBS - Sale$83.12-39,0001,627,296-2%-$3,241,618
M
2018-08-02
NEOGNeogen CorpHerbert James LExec COBS - Sale$81.96-26,0001,214,261-2%-$2,131,016
2018-08-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$13.15-3,00012,000-20%-$39,450
D
2018-07-31
NEOGNeogen CorpBoehm William TDirS - Sale+OE$82.15-4,00010,479-28%-$328,603
M
2018-07-30
NEOGNeogen CorpHerbert James LExec COBS - Sale$81.78-39,0001,240,261-3%-$3,189,462
D
2018-07-30
NEOGNeogen CorpReed Thomas HDirS - Sale+OE$80.41-22,00013,373-62%-$1,769,020
D
2018-07-26
OCXOncocyte CorpAnnett WilliamPres, CEOP - Purchase$0.00+3,5003,500New+$0
D
2018-07-26
OCXOncocyte CorpAndrews Ronald AsburyDirP - Purchase$0.00+17,48217,482New+$0
D
2018-07-26
OCXOncocyte CorpLevine Mitchell SCFOP - Purchase$0.00+3,4953,495New+$0
D
2018-07-26
OCXOncocyte CorpRedmond Cavan M.DirP - Purchase$0.00+52,44752,447New+$0
D
2018-07-26
OCXOncocyte CorpHesterberg Lyndal K.SVP, Research, DevelopmentP - Purchase$0.00+874874New+$0
D
2018-07-26
OCXOncocyte CorpLast Andrew J.DirP - Purchase$0.00+6,9936,993New+$0
D
2018-07-26
OCXOncocyte CorpArno AndrewDirP - Purchase$0.00+52,44752,447New+$0
DM
2018-07-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$66.93-36,000294,313-11%-$2,409,384
2018-07-26
NEOGNeogen CorpHerbert James LExec COBS - Sale$82.50-13,0001,279,261-1%-$1,072,548
2018-07-23
NEOGNeogen CorpHerbert James LExec COBS - Sale$82.04-16,0291,292,261-1%-$1,314,985
D
2018-07-23
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$82.01-3,80213,470-22%-$311,816
D
2018-07-20
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$82.14-15,46837,575-29%-$1,270,498
2018-07-20
NEOGNeogen CorpReed Thomas HDirS - Sale$82.56-5,3338,040-40%-$440,286
2018-07-18
NEOGNeogen CorpHerbert James LNon Exec COBS - Sale$82.20-38,6001,308,290-3%-$3,173,100
2018-07-16
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$31.17-6,6861,615,3210%-$208,397
D
2018-07-12
QDELQuidel Corp /de/Russell Edward KeithS.VP, N.A. Commercial OpsS - Sale+OE$68.09-10,0008,887-53%-$680,938
DM
2018-06-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$66.05-36,000294,313-11%-$2,377,644
2018-06-25
LNTHLantheus Holdings, Inc.McHugh JulieDirS - Sale$14.72-4,56014,752-24%-$67,123
2018-06-19
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$27.96-6,6861,836,8100%-$186,908
D
2018-06-18
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$40.12-60,000138,809-30%-$2,407,200
D
2018-06-18
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$40.00-33,000124,197-21%-$1,320,000
2018-06-15
IMMUImmunomedics IncVenbio Select Advisor LLCSee Remarks, 10%P - Purchase$23.39+200,00017,714,461+1%+$4,678,000
2018-06-15
CLDXCelldex Therapeutics, Inc.Keler TiborEVP, CSOP - Purchase$0.59+16,50035,368+87%+$9,783
2018-06-15
IMMUImmunomedics IncVenbio Select Advisor LLCSee Remarks, 10%P - Purchase$24.00+575,00017,514,461+3%+$13,800,000
2018-06-12
QDELQuidel Corp /de/Kroll WernerSVP, R, DS - Sale$66.16-2,50016,005-14%-$165,392
DM
2018-06-11
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale+OE$65.00-26,55513,134-67%-$1,726,075
DM
2018-06-06
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$39.35-20,36939,743-34%-$801,594
DM
2018-06-05
MYGNMyriad Genetics IncGilbert Walter PhdDirS - Sale+OE$39.69-30,00027,243-52%-$1,190,589
DM
2018-06-01
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$39.30-49,63139,743-56%-$1,950,277
D
2018-05-30
MYGNMyriad Genetics IncCapone Mark ChristopherPres, C.E.O.S - Sale+OE$38.00-90,000332,175-21%-$3,420,000
D
2018-05-30
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$38.00-33,139123,769-21%-$1,259,282
D
2018-05-30
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$37.92-10,00039,743-20%-$379,245
DM
2018-05-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$62.08-36,000294,313-11%-$2,234,700
D
2018-05-30
IDXXIdexx Laboratories Inc /deStuder JacquelineCVP, Gen. Counsel, SecretaryS - Sale+OE$209.98-4755,825-8%-$99,741
2018-05-29
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale$204.37-1,62614,150-10%-$332,306
D
2018-05-25
QDELQuidel Corp /de/Brown Thomas DDirS - Sale+OE$61.34-30,45153,958-36%-$1,867,864
M
2018-05-22
QTNTQuotient LtdPerceptive Advisors LLC10%P - Purchase$6.45+450,0006,483,020+7%+$2,903,117
D
2018-05-21
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$35.90-10,00039,743-20%-$359,000
2018-05-16
NEOGNeogen CorpPapesh G BruceDirS - Sale$72.50-6,00026,261-19%-$435,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top